Ropes & Gray Advised on Relay Therapeutics’ Public Offering Pricing

In The News
May 21, 2026
Ropes & Gray represented the underwriters in Relay Therapeutics’ offering of 22,916,667 shares of its common stock at a public offering price of $12 per share. Relay Therapeutics also granted the underwriters a 30-day option to purchase up to an additional 3,437,500 shares of its common stock. The transaction priced on May 20.

Relay Therapeutics is a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living with cancer and genetic disease. Relay Therapeutics’ Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed.

The Ropes & Gray team was led by capital markets partner Will Michener and included IP transactions partner Melissa Rones, IP transactions counsel Ryan Murphey and capital markets associate Joseph Markel.